Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Sublingual abuse-resistant tablets comprising buprenorphine and naloxone.
No-Receipt date
2021-03953 - 13/10/2021
No-Filing date
20210402741 - 13/10/2021
No-Granting date
3108661 - 22/10/2021
No-EPO application date
15156024.0 - 18/09/2012
No-EPO granting date
2915525 - 11/08/2021
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
10/2021 - 11/11/2021
Expiration date
19/09/2032
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201161536180 P19/09/2011/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61P 25/36
A61P 25/30
A61P 25/04
A61K 9/20
A61K 9/00
A61K 31/485
A61K 31/4748
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1352307
OREXO AB
BOX 303
751 05 UPPSALA
SWEDEN
Inventors
Code
Firstname
Surname
3473027
FISCHER, ANDREAS
Representatives
Code
Firstname
Surname
Address
Town
Zip
3463
MARIA
ATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Payments history
13 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).